Incorporating Novel Biomarkers into Routine Testing for Earlier, Presymptomatic Detection of Neurodevelopmental & Neuro-Oncology Indications

• Case study 1: Leveraging protein factors found specifically in amniotic fluid todetect autism prior to third trimester
• Case study 2: Utilizing CRISPR technology to identify markers present before the onset of glioblastoma

Speakers:

Mashlika Prasanth

Senior Research Officer, Neuroscience

Johnson & Johnson